International journal of clinical pharmacology and therapeutics
GLP-1s are great if blood sugar swings or plateaus are part of your picture
The share of the public who report having heard about these drugs has increased since July 2023 when seven in ten adults reported having heard at least a little about these drugs and one in five (19%) said they had heard a lot. The share who say they have heard a lot about these drugs rises to at least four in ten among those who have ever been told by a doctor that they have diabetes (45%) or heart disease (41%) or have been told by a doctor in the past five years that they are overweight or obese (42%) the primary conditions these drugs are prescribed for
Sikiric, P., Seiwerth, S., Grabarevic, Z., Rucman, R., Petek, M., Jagic, V., Turkovic, B., Rotkvic, I., Mise, S., Zoricic, I., Konjevoda, P., Perovic, D., Simicevic, V., Separovic, J., Hanzevacki, M., Ljubanovic, D., Artukovic, B., Bratulic, M., Tisljar, M., & Rekic, B
It was initially developed to treat type 2 diabetes, but it has become a popular choice for those seeking significant weight loss
Mitochondrial fatty acid oxidation regulates monocytic type I interferon signaling via histone acetylation